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Breast cancer is the commonest issue in public health. The screening method particularly clinically-breast exam-
ination is likely to drive the leading for early diagnosis of breast cancer, and breast cancer awareness is the
key to encouraging in help seeking these treatments. Several breast cancer awareness instruments have been
developed that the authors report as validated. However, instruments like those are highly contextualized to
particular health care settings. The aim of this study was to develop the BCAS instrument among Indonesian
women. Indonesian women aged 18 to 80 years were selected by stratified random sampling in five munici-
palities in Yogyakarta provinces by two locations (rural–urban) combinations were collected. Parallel analysis
based on confirmatory factor analysis was conducted. The association of the BCAS-I subscales with participant
characteristics was undertaken using proportional odds ordinal logistic regression. The questionnaires were
completed by 200 Indonesian women (100% response rate). The average age was 36 (SD = 12) and ranged
from 18 to 74 years old. Most participants resided in rural areas (62%), and 60% didn’t have health insurance.
According to the parallel analysis, a five-factor solution was used. The factor solution was followed: knowledge of
risk factors, knowledge of signs and symptoms, attitude to breast cancer prevention, a barrier of breast screen-
ing, and health behavior related to breast cancer awareness. And the alpha value of 0.78 indicates sufficiently
high reliability to provide confidence interpreting the score. This study demonstrated that the BCAS-I tool is
shown to valid and reliable in Yogyakarta women, Indonesia. Psychometric properties are needed to determine
the construct, concurrent, criterion, and predictive validity of the BCAS-I scale.
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1. INTRODUCTION
Globally, breast cancer is the commonest issue in public health.
Breast cancer is second diagnosed in the globe. The incidence
rate of breast cancer predicted a quarter million new cancer cases
of overall cancer cases in worldwide. While the mortality rate
of breast cancer is the fifth cause of death in the total of cancer
mortality.1–3 In developing countries, breast cancer is the high-
est incidence.1 Breast cancer may be cured through changing
lifestyle, including less physical activity, higher levels of obesity
and alcohol consumption.2
Moreover, breast cancer death is rising in Asian women.4–6
Meanwhile, breast cancer incidence is the famous new cases in
Indonesia in particular,78 and one of the problems in developing
countries, such as Indonesia is that diagnosis of breast cancer
occurs late presentation in breast cancer.
∗Author to whom correspondence should be addressed.
Several campaigns to reduce the mortality rate of breast can-
cer have been trialed in developing countries, while difficulties
in the deployment drive to the inefficiency of such programs,
particularly in low and middle-income countries.9 Those due to
no routine mammographic in their application in health care
settings,1011 Limited financial and other resources considered in
those countries, awareness breast cancer is possible may reduced
mortality rate in breast cancer. Thus early diagnosis in breast
cancer can achieve through their empowering in these programs.
Socioeconomic of Indonesian women, belief, and culture led
predictor variables with late presentation in breast cancer.12
Besides, lower in help seeking in a treatment of breast can-
cer seems to influence poor survival time of breast cancer.13–15
Early warning of breast cancer through breast cancer awareness
is essential to reducing the mortality rate of breast cancer in par-
ticular. Furthermore, increasing awareness represents a feasible
and costly effective method in countries with resource-limited
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health care, especially those that don’t have ongoing organized
population-based screening.15
The screening method particularly clinically-breast examina-
tion is likely to drive the leading for early diagnosis of breast
cancer, and breast cancer awareness is the key to encouraging
in help seeking in a treatment of breast cancer. Numerous stud-
ies into breast cancer awareness have been conducted in the
West16–19 and breast cancer awareness instruments used for these
studies have been developed especially for this context, and are
unlikely to be valid in developing countries. In recent days, ade-
quately validated instruments for breast cancer awareness seems
conducted across cultures, or even outside the health care setting
in which they were developed.
Several breast cancer awareness instruments have been devel-
oped that the authors report as validated. For example, breast-
BCAM17 was developed for women in the UK. However,
instruments like those are highly contextualized to particular
health care settings. Indeed, BCAM actually mentions the British
mammographic screening program among its items, reducing its
usefulness outside of the UK setting. The inadequacy of a West-
ern developed breast cancer awareness tools for application to
Asian populations is likely to lead to several problems. Beliefs
and misconceptions are likely to be driven, at least in part,
by cultural context.20–24 An instrument developed and validated
on Western women may not be assumed to be valid in Asian
populations.
The B-CAS (Breast Cancer Awareness Scale) tool was devel-
oped and validated for measuring breast cancer awareness in
Thai women.25 Unlike many previously developed instruments
for measuring breast cancer awareness, the B-CAS went through
an appropriate and thorough validation. The aim of this study
was developing the BCAS instrument among Indonesian women.
2. MATERIALS AND METHOD
2.1. Participants
Indonesian women aged 18 to 80 years were selected by stratified
random sampling in five municipalities in Yogyakarta provinces
by two location (rural–urban) combinations were collected. We
felt these municipality-location combinations adequately repre-
sented the spectrum of cultures, religions, and socioeconomics in
Yogyakarta women. Then, the questionnaire was administered in
March to May 2016 to women with no history of breast cancer,
who were neither pregnant nor breastfeeding, and was literate in
the Indonesian language.
Measuring sample size for establishing psychometric proper-
ties is not clearly defined. However, a total of 100 participants has
represented a sufficient sample size of evaluating explanatory fac-
tor analysis (EFA).26 All of the total 200 Yogyakarta women were
obtained from all questionnaires distributed (response rate =
100%). Informed consent was obtained from all individual partic-
ipants included in this study. The approving research was issued
by the Ethics Committee of Khon Kaen University (HE582369),
Thailand and a letter research permit from The Indonesian Min-
istry of Home Affairs (No. 440.02/1085/Polpum).
2.2. Measurement
The BCAS-I instrument divided into two sections. Firstly, the
BCAS-I contained 14 questions as follows: age, province, region,
educational level, marital status, monthly income, religion, cur-
rent occupation, health insurance, family breast cancer history,
family (any) cancer history, tobacco use, alcohol consump-
tion, breastfeeding history. Secondly, the BCAS-I contained five
domains include knowledge of risk factors, knowledge of signs
and symptoms, attitude to breast cancer prevention, a barrier
of breast screening, and health behavior related to breast can-
cer awareness. The two knowledge domains were weighed as
yes/don’t know/no. The domain of both attitudes to breast can-
cer prevention and barriers to breast screening were rated using
a 5-point Likert scale from strongly disagree to agree strongly.
The health behavior related to breast cancer awareness domain
was measured using a 5-point frequency scale.
2.3. Statistical Analysis
Demographic data of the participants in this study were sum-
marized using descriptive statistics. EFA and confirmatory factor
analysis (CFA) was a method to confirm the construct validity
of instrument model so as to seek a single or set of predefined
constructs.2728 EFA was used to determine the number of latent
factors (initially) or the pattern of relationships between the com-
mon factors and the indicators. CFA was used to test and modify
the model that emerged from the EFA and specify the number
of factors and the pattern of indicator-factor loadings.29 Paral-
lel analysis based on Principal Components Analysis was used
to determine the nature of the underlying factors.30 An Oblique
(Promax) model was chosen after comparing principal axis fac-
toring models with orthogonal (Varimax) and oblique rotations.
The proposed measurement model is provided in Figure 1.
Cronbach’s alpha coefficient examined the internal consistency
of the BCAS-I instrument. Reliability coefficient over 0.70 was
considered acceptable.31 Finally, the association of the BCAS-I
subscales with participant characteristics was undertaken using
proportional odds ordinal logistic regression. The data was coded
in Epidata software version 3.1, and all analysis was performed
using the R statistics package (R CRAN team version 2.3.0,
2015); the R libraries Lavaan32 and semPlot.33 A significance
level of 0.05 will be used throughout all analysis.
Fig. 1. Measurement model for breast cancer awareness scale Indonesian
(BCAS-I).
12590
R E S E A R CH A R T I C L EAdv. Sci. Lett. 23, 12589–12593, 2017
3. RESULTS AND DISCUSSION
3.1. Sample Characteristics
The questionnaires were completed by 200 Indonesian women
(100% response rate). The average age was 36 (SD = 12) and
ranged from 18 to 74 years old. Most participants resided in
rural areas (62%), and 60% didn’t have health insurance. The
participant characteristics are shown in Table I.
Principal axis factoring with oblique rotations was then
employed to explore the factor structure and the resulting load-
ings are given in Figure 2. And the coefficient in this pattern
matrix was reported in Table II. The factor solution was follow-
ing: (1) knowledge of risk factors (RF: 9 items), knowledge of
signs and symptoms (SS: 8 items), attitude to breast cancer pre-
vention (AT: 6 items), barrier of breast screening (BAR: 4 items),
Table I. Characteristics of breast cancer awareness in the confirma-
tory factor analysis.
Items Number %
Age
Early adulthood (18–34 y) 99 493
Adulthood (35–59 y) 84 418
Elderly (>60 y) 7 35
District
Yogyakarta 24 12
Bantul 60 30
Sleman 54 27
Kulonprogo 23 11
Gunungkidul 40 20
Locale
Rural 50 25
Urban 151 75
Education level
Primary school 19 95
Junior high school 17 85
Senior high school 84 418
Bachelor degree 74 368
Postgraduate degree 7 35
Marital status
Single 46 23
Married 145 72
Widowed/separate/discovered 10 5
Monthly income
<2,000,000 IDR 155 771
≥2,000,000 to 6,000,000 IDR 46 229
Religion
Muslim 92 955
Christians 4 2
Others 5 25
Occupation
No employment (include housewives) 34 17
Farmer 23 11
Trader 30 15
Laborer 49 24
Government/official/enterprise/business 36 18
Student 29 14
Others
Health insurance
Yes 123 61
No 78 39
Smoking history
Yes 2 1
No 199 99
Alcohol history
Yes 200 995
No 1 05
Fig. 2. Parallel analysis derived from a confirmatory factor analysis.
and health behavior related to breast cancer awareness (BEH:
6 items).
3.2. Reliability
The reliability of the BCAS-I was evaluated using Cronbach’s
alpha demonstrated that a good level of internal consistency with
the alpha value of 0.78 indicates sufficiently high reliability to
provide confidence interpreting the score.
4. DISCUSSION
We successfully developed the first instrument of breast can-
cer awareness Indonesian scale (BCAS-I) based on Yogyakarta,
Indonesian women who were adapted to cultural contexts/health
care settings in Indonesia. According to the factor analysis, we
produced factors considered breast cancer awareness scale as fol-
lows: (1) knowledge of risk factors (RF: 9 items), knowledge of
signs and symptoms (SS: 8 items), attitude to breast cancer pre-
vention (AT: 6 items), barrier of breast screening (BAR: 4 items),
and health behavior related to breast cancer awareness (BEH:
6 items). The results of this study indicated the factor solution for
the BCAS-I scale is promising to use in Indonesian culture con-
text. The internal consistency demonstrated adequate reliability
for the instrument measuring four subscales, as all subscales were
higher than 0.70. Also, all items of the BCAS-I structure were
strongly well with the hypothesis in their construct. Moreover, we
regard to the construct validity, and all participants characteristics
indicated that they obtained strongly association on each sub-
scale. We also found the BCAS-I has reached validation strongly
to lend particular importance to our BCAS-I-based study because
it constitutes the first step towards achieving better understanding
women’s awareness knowledge about breast cancer and symp-
toms of the disease. It can encourage them to perform better
and timelier breast self-exams among Indonesian women. The
BCAS-I can likely lead evaluating breast cancer awareness to
achieve prevention strategies through public education to reduce
the known risk factor of breast cancer.34–37
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Table II. Standardized loading factors for explanatory factor analysis in the BCAS-I.
Factor loading
Standardized loading
Domains factors 1 2 3 4 5 h2
Knowledge of risk factors (9 items)
RF1 Family history of breast cancer 0500 0.26 0.278
RF2 Use of birth control pills 0516 0.38 0.240
RF3 Having undergone hormone replacement therapy 0737 0.40 0.454
RF4 Beginning your menses before the age of 12 0589 0.64 0.486
RF5 Menopause after the age of 55 0541 0.78 0.575
RF6 Infertility 0664 0.71 0.579
RF7 Giving birth after the age of 30 0601 0.69 0.501
RF8 Eating fatty foods 0577 0.35 0.363
RF9 Obesity 0561 0.39 0.368
Knowledge signs and symptoms (8 items)
SS1 Bleeding or liquid discharge from the nipple 0640 0.60 0.433
SS2 Swelling in the breast or armpit area. 0801 0.79 0.757
SS3 Changes in the shape, size or color around the breast or nipple 0668 0.50 0.472
SS4 Pain in the breast or armpit area 0719 0.71 0.589
SS5 Sensation of the nipple being pulled from the inside 0629 0.46 0.345
SS6 A lump or thickness of skin beneath the armpit 0716 0.61 0.541
SS7 Puckering or dimpling/scaling around the breast 0753 0.53 0.482
SS8 A lump or thickness of skin in the breast area 0743 0.66 0.605
Attitude to breast cancer prevention (6 items)
AT1 Breast cancer can be avoided by decreasing the risk 0688 0.66 0.555
factors of breast cancer
AT2 Breast cancer can be cured if it is detected in its first stage 0820 0.75 0.650
AT3 Breast cancer can be detected in its first stage by having routine 0813 0.71 0.567
check-ups with a doctor/health specialist
AT4 Routine mammogram tests can detect breast cancer in its first stage. 0810 0.69 0.540
AT5 Exercise can reduce the risk of breast cancer 0518 0.55 0.413
AT6 Reducing fatty foods can decrease the risk of breast cancer 0397 0.48 0.370
Barrier of breast screening (4 items)
BAR1 I don’t feel comfortable going to the doctor for a breast screening 0690 0.59 0.488
BAR2 Breast check-ups involve too much time waiting in line 0701 0.62 0.483
BAR3 I am busy and don’t have time to go the doctor for a breast check-up 0649 0.65 0.463
BAR4 I don’t know how to check a breast self-examination 0734 0.55 0.491
Health behavior related to breast cancer awareness (7 items)
BEH1 How often do you eat fried food? 0057 0.28 0.111
BEH4 How often do you eat fresh vegetables? −0063 0.27 0.082
BEH7 How often did you perform breast self examination by yourself −2419 0.36 0.406
BEH8 How often do you get breast check-ups at health clinics? −0093 0.62 0.422
BEH9 How often do you get mammogram tests? −0028 0.51 0.305
Notes: ∗∗∗Strongly loading items; +: Item constrained.
In present results in this study showed reaching an Indonesian
scale of breast cancer awareness with 33 items were included
in a 5-domains model for the CFA of the BCAS-I. According
to the dimensions available in previous studies and the dimen-
sions present from this study, a conceptual model was created to
show the relationship between the factors underlying breast can-
cer awareness (Fig. 3). We validated the BCAS-I, achieving an
ideal fit without two the original items of health behavior asso-
ciated with breast cancer awareness 2 (How many days per week
do you eat food or dessert with coconut?) and 3 (How often do
you eat beef, chicken, or duck with the fat or skin?). Two items
of health behavior (e.g., BEH 2 and BEH 3) were removed due
to it did not load significantly on its corresponding structure in
the BCAS-I. Nonetheless, the high internal consistency reliability
was reached in our instrument. A good model fit of the BCAS-I
was in line with previous work testing the psychometric prop-
erties of English, and the Thai version of these scales.16172538
Why is ours better than others (e.g., the BCAM)17 was devel-
oped specially for the UK health system and actually refers to
specific programs (e.g., mammography screening) offered this is
health setting. The BCAM is unlikely to be appropriate anywhere
outside of the UK. B-CAS, on the other hand, could be only
adjusted for different cut point; indeed it was originally devel-
oped for Thai women. The BCAS-I, this was likely adapted to
the cultural context and a particular health setting in Indonesia.
The limitation of this study was acknowledgment. According
to cross-sectional in this study, some bias was identified, such as
most of Indonesian is well known as rich culture and Muslim.
In order taking one province particularly, Yogyakarta may not
represent the several cultures and ethnic of Indonesian. Also,
another limitation is the most of the women was poor educated
which was inadequate knowledge of breast cancer might raise
concerns about selection bias.
Strengths of this study should be noted. This study is the
first develop in Indonesian women particularly in Yogyakarta.
Although only women were included in this study, they demon-
strated a relatively wide range of age (from 18 to 80) years) and
were distributed across various education levels.
5. CONCLUSION
Finally, we concluded the results of this study demonstrated that
the BCAS-I tool is shown to valid and reliable in Yogyakarta
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women, Indonesia. In the future, psychometric is needed to deter-
mine the construct, concurrent, criterion, and predictive validity
of the BCAS-I scale.
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